175 related articles for article (PubMed ID: 15283408)
1. [Learning curve and early complications of totally implantable venous access devices: is tutoring the solution for the problem?].
Di Carlo I; Toro A; Sofia M; Fasone MA; Barbagallo F; Russello D
G Chir; 2004 Apr; 25(4):146-8. PubMed ID: 15283408
[TBL] [Abstract][Full Text] [Related]
2. Increased use of percutaneous technique for totally implantable venous access devices. Is it real progress? A 27-year comprehensive review on early complications.
Di Carlo I; Pulvirenti E; Mannino M; Toro A
Ann Surg Oncol; 2010 Jun; 17(6):1649-56. PubMed ID: 20204533
[TBL] [Abstract][Full Text] [Related]
3. [Complications after insertion of a totally implantable venous access port in patients treated with chemotherapy for head and neck squamous cell carcinoma].
Hoareau-Gruchet F; Rtail R; Sulaj H; Khirnetkina A; Reyt E; Righini CA
Ann Otolaryngol Chir Cervicofac; 2009 Apr; 126(2):43-52. PubMed ID: 19324328
[TBL] [Abstract][Full Text] [Related]
4. [Totally implantable venous access systems. Analysis of complications].
D'Angelo F; Ramacciato G; Caramitti A; Aurello P; Lauro S; Bordin F; Della Casa U
Minerva Chir; 1997; 52(7-8):937-42. PubMed ID: 9411296
[TBL] [Abstract][Full Text] [Related]
5. [Assessment of patient's comfort and functioning of a totally implantable venous system placed in the safenous vein].
Toro A; Sofia M; Sparatore F; Lombardo R; Cordio S; Di Carlo I
G Chir; 2005; 26(6-7):282-5. PubMed ID: 16332308
[TBL] [Abstract][Full Text] [Related]
6. Subclavian vein stenosis following totally implantable venous access device (TIVAD) implant by percutaneous approach. Case report.
Di Carlo I; Fasone MA; Toro A; Castello G; Sparatore F; Cordio S
G Chir; 2004; 25(11-12):417-9. PubMed ID: 15803820
[TBL] [Abstract][Full Text] [Related]
7. Use of subcutaneous implantable infusion systems in neoplastic and AIDS patients requiring long-term venous access.
Dionigi P; Cebrelli T; Jemos V; Minoli L; Gobbi P; Dimitrov G
Eur J Surg; 1995 Feb; 161(2):137-42. PubMed ID: 7772631
[TBL] [Abstract][Full Text] [Related]
8. Experience of totally implantable venous access devices (TIV ADs) in adults with cystic fibrosis over a 13-year period.
Kariyawasam HH; Pepper JR; Hodson ME; Geddes DM
Respir Med; 2000 Dec; 94(12):1161-5. PubMed ID: 11192950
[TBL] [Abstract][Full Text] [Related]
9. Cephalic vein cut-down verses percutaneous access: a retrospective study of complications of implantable venous access devices.
Jablon LK; Ugolini KR; Nahmias NC
Am J Surg; 2006 Jul; 192(1):63-7. PubMed ID: 16769277
[TBL] [Abstract][Full Text] [Related]
10. Seat belt associated central line fracture--a previously unreported complication in cystic fibrosis.
Ghayyda SN; Roland D; Cade A
J Cyst Fibros; 2008 Sep; 7(5):448-9. PubMed ID: 18455967
[TBL] [Abstract][Full Text] [Related]
11. Complications of vascular access devices.
Johnson JC
Emerg Med Clin North Am; 1994 Aug; 12(3):691-705. PubMed ID: 8062794
[TBL] [Abstract][Full Text] [Related]
12. A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients.
Araújo C; Silva JP; Antunes P; Fernandes JM; Dias C; Pereira H; Dias T; Fougo JL
Eur J Surg Oncol; 2008 Feb; 34(2):222-6. PubMed ID: 17566692
[TBL] [Abstract][Full Text] [Related]
13. External jugular vein cutdown approach, as a useful alternative, supports the choice of the cephalic vein for totally implantable access device placement.
Di Carlo I; Barbagallo F; Toro A; Sofia M; Lombardo R; Cordio S
Ann Surg Oncol; 2005 Jul; 12(7):570-3. PubMed ID: 15889215
[TBL] [Abstract][Full Text] [Related]
14. Management of functional complications of totally implantable venous access devices by an advanced practice nursing team: 5 years of clinical experience.
Goossens GA; Stas M; Moons P
Eur J Oncol Nurs; 2012 Dec; 16(5):465-71. PubMed ID: 22265937
[TBL] [Abstract][Full Text] [Related]
15. [Cephalic vein access for implantable venous access devices. Technique and long-term follow-up].
Conessa C; Talfer S; Herve S; Chollet O; Poncet JL
Rev Laryngol Otol Rhinol (Bord); 2002; 123(3):143-8. PubMed ID: 12577777
[TBL] [Abstract][Full Text] [Related]
16. Totally implantable venous access devices: evaluation of complications and a prospective comparative study of two different port systems.
Hartkamp A; van Boxtel AJ; Zonnenberg BA; Witteveen PO
Neth J Med; 2000 Dec; 57(6):215-23. PubMed ID: 11099790
[TBL] [Abstract][Full Text] [Related]
17. Surgical technique for totally implantable access ports (TIAP) needs improvement: a multivariate analysis of 400 patients.
Seiler CM; Frohlich BE; Dorsam UJ; Kienle P; Buchler MW; Knaebel HP
J Surg Oncol; 2006 Jan; 93(1):24-9. PubMed ID: 16353193
[TBL] [Abstract][Full Text] [Related]
18. Feasibility and safety of endovascular stripping of totally implantable venous access devices.
Heye S; Maleux G; Goossens GA; Vaninbroukx J; Jerôme M; Stas M
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):607-12. PubMed ID: 21479744
[TBL] [Abstract][Full Text] [Related]
19. [Percutaneous implant of Hickman catheters and reservoirs. Long-term experience].
Carreira Villamor JM; Reyes Pérez R; Pulido-Duque JM; Gorriz Gómez E; Pardo MD; Argiles Vives JM; Eyheremendy EP; Maynar Moliner M
Rev Clin Esp; 1997 Nov; 197(11):740-4. PubMed ID: 9547192
[TBL] [Abstract][Full Text] [Related]
20. Totally implanted device for long-term intravenous chemotherapy: experience in 123 adult patients with solid neoplasms.
Puig-la Calle J; López Sánchez S; Piedrafita Serra E; Allende Honorato L; Artigas Raventós V; Puig la Calle J
J Surg Oncol; 1996 Aug; 62(4):273-8. PubMed ID: 8691841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
